ADIAL PHARMACEUTICALS, INC.
Pharmaceutical Preparations · CHARLOTTESVILLE · VA
Moderate confidence (50%)
Updated Sep 18, 2026, 01:34 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: ADIAL PHARMACEUTICALS, INC. received a delisting notice from its exchange (Aug 18, 2026)
Timeline
Every material event, newest first. History is never overwritten.
ADIAL PHARMACEUTICALS, INC. received a delisting notice from its exchange
Aug 18, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 18, 2026, Adial Pharmaceuticals, Inc. (the Company ) received a letter (the Notice ) from The Nasdaq Stock Market ( Nasdaq ) notifying the Company that, based on the stockholders equity reported in the Company s Quarterly Report on Form 10-Q for the period ended June 30, 2026, the Company no longer satisfies the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1) (the Stockholders Equi…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker ADIL on Nasdaq.
- SEC CIK
- 0001513525
- Website
- —
- —
- Headquarters
- CHARLOTTESVILLE, VA
- Also known as
- Adial Pharmaceuticals, L.L.C.
- Legal entities
- ADIAL PHARMACEUTICALS, INC.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
ADIAL PHARMACEUTICALS, INC. — Pharmaceutical Preparations (SIC 2834) — CHARLOTTESVILLE, VA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 18, 2026, Adial Pharmaceuticals, Inc. (the Company ) received a letter (the Notice ) from The Nasdaq Stock Market ( Nasdaq ) notifying the Company that, based on the stockholders equity reported in the Company s Quarterly Report on Form 10-Q for the period ended June 30, 2026, the Company no longer satisfies the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1) (the Stockholders Equi…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.